Grants and Contributions:
Title:
Pilot Study to Assess Efficacy of Two Novel DNA Vaccines Against Sea Lice
Agreement Number:
916915
Agreement Value:
$44,967.00
Agreement Date:
Dec 3, 2018 - Feb 28, 2020
Description:
The work proposed will take an innovative approach to the control and prevention of sea lice infection using DNA technology to prevent lice from causing infection by blocking their ability to survive on the host.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1A 3H4
Reference Number:
172-2018-2019-Q3-916915
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
808567390
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.
Amendment Date
Jul 24, 2019
Recipient's Legal Name:
RPS Biologiques Inc.
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32541
Amendments: